Toggle navigation
Works
People
Organizations
Repositories
Pages
About
Statistics
Support
Sign In
Loading...
Loading...
Mass drug administration for malaria during emergencies, periods of health service disruption, or epidemics of febrile illness
https://doi.org/10.5281/zenodo.6535553
Loading...
Download Metadata
Cite as
APA
Harvard
MLA
Vancouver
Chicago
IEEE
Download Reports
Related Works (CSV)
Share
Email
Twitter
Facebook
Description
Other Identifiers
Creators
Registration
Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.6.2 MDA for burden reduction in emergency settings” of the WHO Guidelines for malaria, 3 June 2022.
URL:
https://zenodo.org/record/6535554
Sayre D
Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
Moriarty L
Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
Westercamp N
Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
Knipes A
Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
Shah M
Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
DOI registered
June 2, 2022
via DataCite
Content published 2022 in
Zenodo
Report
English